{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T21:36:17Z","timestamp":1794864977954,"version":"4.9.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Research Project of Henan Provincial Health and Wellness Committee and National Traditional Chinese Medicine Inheritance and Innovation Center jointly build a special scientific research project","award":["2024ZXZX1123"],"award-info":[{"award-number":["2024ZXZX1123"]}]},{"name":"Henan Province traditional Chinese medicine double first class to create a special project for scientific research","award":["HSRP-DFCTCM-2023-5-08"],"award-info":[{"award-number":["HSRP-DFCTCM-2023-5-08"]}]},{"name":"Doctoral Research Start up Fund of the First Affiliated Hospital of Henan University of Chinese Medicine","award":["2022BSJJ2001"],"award-info":[{"award-number":["2022BSJJ2001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"DOI":"10.1186\/s12887-025-06501-y","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T13:35:58Z","timestamp":1768397758000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association and predictive value of blood branched-chain and excitatory amino acids with autism spectrum disorder severity"],"prefix":"10.1186","volume":"26","author":[{"given":"Jing","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangliang","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueli","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiushuang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weili","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongyi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,14]]},"reference":[{"issue":"5","key":"6501_CR1","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.biopsych.2020.09.025","volume":"89","author":"BD Needham","year":"2021","unstructured":"Needham BD, Adame MD, Serena G, Rose DR, Preston GM, Conrad MC, Campbell AS, Donabedian DH, Fasano A, Ashwood P, et al. Plasma and fecal metabolite profiles in autism spectrum disorder. Biol Psychiatry. 2021;89(5):451\u201362.","journal-title":"Biol Psychiatry"},{"issue":"2","key":"6501_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.ss7402a1","volume":"74","author":"KA Shaw","year":"2025","unstructured":"Shaw KA, Williams S, Patrick ME, Valencia-Prado M, Durkin MS, Howerton EM, Ladd-Acosta CM, Pas ET, Bakian AV, Bartholomew P, et al. Prevalence and early identification of autism spectrum disorder among children aged 4 and 8 Years - autism and developmental disabilities monitoring Network, 16 Sites, united States, 2022. MMWR Surveill Summ. 2025;74(2):1\u201322.","journal-title":"MMWR Surveill Summ"},{"key":"6501_CR3","doi-asserted-by":"crossref","unstructured":"Salehi M, Jaka S, Lotfi A, Ahmad A, Saeidi M, Gunturu S. Prevalence, Socio-Demographic Characteristics, and Co-Morbidities of Autism Spectrum Disorder in US Children: Insights from the 2020\u20132021 National Survey of Children\u2019s Health. Child (Basel). 2025;12(3).","DOI":"10.3390\/children12030297"},{"issue":"2","key":"6501_CR4","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S2215-0366(24)00363-8","volume":"12","author":"DF Santomauro","year":"2025","unstructured":"Santomauro DF, Erskine HE, Mantilla Herrera AM, Miller PA, Shadid J, Hagins H, Addo IY, Adnani QES, Ahinkorah BO, Ahmed A, et al. The global epidemiology and health burden of the autism spectrum: findings from the global burden of disease study 2021. Lancet Psychiatry. 2025;12(2):111\u201321.","journal-title":"Lancet Psychiatry"},{"issue":"4","key":"6501_CR5","first-page":"504","volume":"69","author":"B Akram","year":"2019","unstructured":"Akram B, Batool M, Bibi A. Burden of care and suicidal ideation among mothers of children with autism spectrum disorder: perceived social support as a moderator. J Pak Med Assoc. 2019;69(4):504\u20138.","journal-title":"J Pak Med Assoc"},{"issue":"1","key":"6501_CR6","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s13229-020-00370-1","volume":"11","author":"C Cheroni","year":"2020","unstructured":"Cheroni C, Caporale N, Testa G. Autism spectrum disorder at the crossroad between genes and environment: contributions, convergences, and interactions in ASD developmental pathophysiology. Mol Autism. 2020;11(1):69.","journal-title":"Mol Autism"},{"issue":"4","key":"6501_CR7","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.biopsych.2018.08.016","volume":"85","author":"AM Smith","year":"2019","unstructured":"Smith AM, King JJ, West PR, Ludwig MA, Donley ELR, Burrier RE, Amaral DG. Amino acid dysregulation metabotypes: potential biomarkers for diagnosis and individualized treatment for subtypes of autism spectrum disorder. Biol Psychiatry. 2019;85(4):345\u201354.","journal-title":"Biol Psychiatry"},{"issue":"6","key":"6501_CR8","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1016\/j.cell.2016.11.013","volume":"167","author":"DC T\u0103rlungeanu","year":"2016","unstructured":"T\u0103rlungeanu DC, Deliu E, Dotter CP, Kara M, Janiesch PC, Scalise M, Galluccio M, Tesulov M, Morelli E, Sonmez FM, et al. Impaired amino acid transport at the blood brain barrier is a cause of autism spectrum disorder. Cell. 2016;167(6):1481\u2013e14941418.","journal-title":"Cell"},{"key":"6501_CR9","doi-asserted-by":"crossref","unstructured":"Prato A, Randazzo M, Messina MA, Puglisi G, Aleo LR, Ciantia F, Cirnigliaro L, Rizzo R, Barone R. Clinical and behavioral correlates of blood acylcarnitine profiles in children with autism spectrum disorder: A Cross-Sectional analysis. Child (Basel). 2025;12(7).","DOI":"10.3390\/children12070848"},{"key":"6501_CR10","doi-asserted-by":"publisher","first-page":"636","DOI":"10.3389\/fpsyt.2018.00636","volume":"9","author":"R Barone","year":"2018","unstructured":"Barone R, Alaimo S, Messina M, Pulvirenti A, Bastin J, Ferro A, Frye RE, Rizzo R. A subset of patients with autism spectrum disorders show a distinctive metabolic profile by dried blood spot analyses. Front Psychiatry. 2018;9:636.","journal-title":"Front Psychiatry"},{"key":"6501_CR11","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3389\/fendo.2019.00247","volume":"10","author":"JHJ van Sadelhoff","year":"2019","unstructured":"van Sadelhoff JHJ, Perez Pardo P, Wu J, Garssen J, van Bergenhenegouwen J, Hogenkamp A, Hartog A, Kraneveld AD. The Gut-Immune-Brain axis in autism spectrum Disorders; A focus on amino acids. Front Endocrinol (Lausanne). 2019;10:247.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"6501_CR12","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.coph.2014.10.007","volume":"20","author":"EJ Lee","year":"2015","unstructured":"Lee EJ, Choi SY, Kim E. NMDA receptor dysfunction in autism spectrum disorders. Curr Opin Pharmacol. 2015;20:8\u201313.","journal-title":"Curr Opin Pharmacol"},{"issue":"5","key":"6501_CR13","first-page":"923","volume":"20","author":"KA Bala","year":"2016","unstructured":"Bala KA, Do\u011fan M, Mutluer T, Kaba S, Aslan O, Balahoro\u011flu R, \u00c7okluk E, \u00dcstyol L, Kocaman S. Plasma amino acid profile in autism spectrum disorder (ASD). Eur Rev Med Pharmacol Sci. 2016;20(5):923\u20139.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"5","key":"6501_CR14","doi-asserted-by":"publisher","first-page":"533","DOI":"10.2174\/1871527315666160413120638","volume":"15","author":"A Sato","year":"2016","unstructured":"Sato A. mTOR, a potential target to treat autism spectrum disorder. CNS Neurol Disord Drug Targets. 2016;15(5):533\u201343.","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"8","key":"6501_CR15","doi-asserted-by":"publisher","first-page":"6031","DOI":"10.1007\/s12035-024-03965-4","volume":"61","author":"Q Gao","year":"2024","unstructured":"Gao Q, Bi D, Li B, Ni M, Pang D, Li X, Zhang X, Xu Y, Zhao Q, Zhu C. The association between Branched-Chain amino acid concentrations and the risk of autism spectrum disorder in Preschool-Aged children. Mol Neurobiol. 2024;61(8):6031\u201344.","journal-title":"Mol Neurobiol"},{"issue":"8","key":"6501_CR16","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1007\/s00702-014-1216-0","volume":"121","author":"DC Rojas","year":"2014","unstructured":"Rojas DC. The role of glutamate and its receptors in autism and the use of glutamate receptor antagonists in treatment. J Neural Transm (Vienna). 2014;121(8):891\u2013905.","journal-title":"J Neural Transm (Vienna)"},{"issue":"4","key":"6501_CR17","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.12998\/wjcc.v10.i4.1206","volume":"10","author":"JH Chu","year":"2022","unstructured":"Chu JH, Bian F, Yan RY, Li YL, Cui YH, Li Y. Comparison of diagnostic validity of two autism rating scales for suspected autism in a large Chinese sample. World J Clin Cases. 2022;10(4):1206\u201317.","journal-title":"World J Clin Cases"},{"issue":"1","key":"6501_CR18","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1186\/s12888-025-06771-x","volume":"25","author":"J Li","year":"2025","unstructured":"Li J, Zhai P, Bi L, Wang Y, Yang X, Yang Y, Li N, Dang W, Feng G, Li P, et al. Associations between amino acid levels and autism spectrum disorder severity. BMC Psychiatry. 2025;25(1):332.","journal-title":"BMC Psychiatry"},{"key":"6501_CR19","doi-asserted-by":"crossref","unstructured":"Thomas SD, Jha NK, Ojha S, Sadek B. mTOR signaling disruption and its association with the development of autism spectrum disorder. Molecules. 2023;28(4).","DOI":"10.3390\/molecules28041889"},{"issue":"6268","key":"6501_CR20","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1126\/science.aad2087","volume":"351","author":"RA Saxton","year":"2016","unstructured":"Saxton RA, Knockenhauer KE, Wolfson RL, Chantranupong L, Pacold ME, Wang T, Schwartz TU, Sabatini DM. Structural basis for leucine sensing by the Sestrin2-mTORC1 pathway. Science. 2016;351(6268):53\u20138.","journal-title":"Science"},{"issue":"6268","key":"6501_CR21","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1126\/science.aab2674","volume":"351","author":"RL Wolfson","year":"2016","unstructured":"Wolfson RL, Chantranupong L, Saxton RA, Shen K, Scaria SM, Cantor JR, Sabatini DM. Sestrin2 is a leucine sensor for the mTORC1 pathway. Science. 2016;351(6268):43\u20138.","journal-title":"Science"},{"key":"6501_CR22","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3389\/fncel.2013.00028","volume":"7","author":"H Wang","year":"2013","unstructured":"Wang H, Doering LC. Reversing autism by targeting downstream mTOR signaling. Front Cell Neurosci. 2013;7:28.","journal-title":"Front Cell Neurosci"},{"issue":"7","key":"6501_CR23","doi-asserted-by":"publisher","first-page":"3003","DOI":"10.1093\/brain\/awad010","volume":"146","author":"T Tangeraas","year":"2023","unstructured":"Tangeraas T, Constante JR, Backe PH, Oyarz\u00e1bal A, Neugebauer J, Weinhold N, Boemer F, Debray FG, Ozturk-Hism B, Evren G, et al. BCKDK deficiency: a treatable neurodevelopmental disease amenable to newborn screening. Brain. 2023;146(7):3003\u201313.","journal-title":"Brain"},{"issue":"2","key":"6501_CR24","first-page":"91","volume":"1","author":"I Manoli","year":"2016","unstructured":"Manoli I, Venditti CP. Disorders of branched chain amino acid metabolism. Transl Sci Rare Dis. 2016;1(2):91\u2013110.","journal-title":"Transl Sci Rare Dis"},{"key":"6501_CR25","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.freeradbiomed.2017.01.009","volume":"104","author":"O Zhenyukh","year":"2017","unstructured":"Zhenyukh O, Civantos E, Ruiz-Ortega M, S\u00e1nchez MS, V\u00e1zquez C, Peir\u00f3 C, Egido J, Mas S. High concentration of branched-chain amino acids promotes oxidative stress, inflammation and migration of human peripheral blood mononuclear cells via mTORC1 activation. Free Radic Biol Med. 2017;104:165\u201377.","journal-title":"Free Radic Biol Med"},{"key":"6501_CR26","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.ijdevneu.2019.07.007","volume":"78","author":"LB Wessler","year":"2019","unstructured":"Wessler LB, de Miranda Ramos V, Bittencourt Pasquali MA, Fonseca Moreira JC, de Oliveira J, Scaini G, Streck EL. Administration of branched-chain amino acids increases the susceptibility to lipopolysaccharide-induced inflammation in young Wistar rats. Int J Dev Neurosci. 2019;78:210\u20134.","journal-title":"Int J Dev Neurosci"},{"issue":"10","key":"6501_CR27","doi-asserted-by":"publisher","first-page":"e25340","DOI":"10.1371\/journal.pone.0025340","volume":"6","author":"C Shimmura","year":"2011","unstructured":"Shimmura C, Suda S, Tsuchiya KJ, Hashimoto K, Ohno K, Matsuzaki H, Iwata K, Matsumoto K, Wakuda T, Kameno Y, et al. Alteration of plasma glutamate and glutamine levels in children with high-functioning autism. PLoS ONE. 2011;6(10):e25340.","journal-title":"PLoS ONE"},{"issue":"1","key":"6501_CR28","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1866-1955-4-4","volume":"4","author":"GA Abu Shmais","year":"2012","unstructured":"Abu Shmais GA, Al-Ayadhi LY, Al-Dbass AM, El-Ansary AK. Mechanism of nitrogen metabolism-related parameters and enzyme activities in the pathophysiology of autism. J Neurodevelopmental Disorders. 2012;4(1):4.","journal-title":"J Neurodevelopmental Disorders"},{"key":"6501_CR29","doi-asserted-by":"crossref","unstructured":"Todd AC, Hardingham GE. The regulation of astrocytic glutamate transporters in health and neurodegenerative diseases. Int J Mol Sci. 2020;21(24).","DOI":"10.3390\/ijms21249607"},{"key":"6501_CR30","doi-asserted-by":"publisher","first-page":"107559","DOI":"10.1016\/j.neuropharm.2019.03.002","volume":"161","author":"E Pajarillo","year":"2019","unstructured":"Pajarillo E, Rizor A, Lee J, Aschner M, Lee E. The role of astrocytic glutamate transporters GLT-1 and GLAST in neurological disorders: potential targets for neurotherapeutics. Neuropharmacology. 2019;161:107559.","journal-title":"Neuropharmacology"},{"issue":"9","key":"6501_CR31","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1212\/WNL.57.9.1618","volume":"57","author":"AE Purcell","year":"2001","unstructured":"Purcell AE, Jeon OH, Zimmerman AW, Blue ME, Pevsner J. Postmortem brain abnormalities of the glutamate neurotransmitter system in autism. Neurology. 2001;57(9):1618\u201328.","journal-title":"Neurology"},{"issue":"5134","key":"6501_CR32","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1126\/science.7901908","volume":"262","author":"JT Coyle","year":"1993","unstructured":"Coyle JT, Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science. 1993;262(5134):689\u201395.","journal-title":"Science"},{"issue":"40","key":"6501_CR33","doi-asserted-by":"publisher","first-page":"8885","DOI":"10.1523\/JNEUROSCI.2476-04.2004","volume":"24","author":"XB Liu","year":"2004","unstructured":"Liu XB, Murray KD, Jones EG. Switching of NMDA receptor 2A and 2B subunits at thalamic and cortical synapses during early postnatal development. J Neurosci. 2004;24(40):8885\u201395.","journal-title":"J Neurosci"},{"issue":"1","key":"6501_CR34","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41398-018-0335-z","volume":"9","author":"E Rosina","year":"2019","unstructured":"Rosina E, Battan B, Siracusano M, Di Criscio L, Hollis F, Pacini L, Curatolo P, Bagni C. Disruption of mTOR and MAPK pathways correlates with severity in idiopathic autism. Translational Psychiatry. 2019;9(1):50.","journal-title":"Translational Psychiatry"},{"key":"6501_CR35","doi-asserted-by":"crossref","unstructured":"Montanari M, Martella G, Bonsi P, Meringolo M. Autism spectrum disorder: focus on glutamatergic neurotransmission. Int J Mol Sci. 2022;23(7).","DOI":"10.3390\/ijms23073861"},{"key":"6501_CR36","doi-asserted-by":"crossref","unstructured":"Kritis AA, Stamoula EG, Paniskaki KA, Vavilis TD. Researching glutamate \u2013 induced cytotoxicity in different cell lines: a comparative\/collective analysis\/study. Front Cell Neurosci. 2015;9.","DOI":"10.3389\/fncel.2015.00091"},{"issue":"1","key":"6501_CR37","doi-asserted-by":"publisher","first-page":"13167","DOI":"10.1038\/s41598-017-13451-8","volume":"7","author":"\u00c1 Anzai","year":"2017","unstructured":"Anzai \u00c1, Marcondes RR, Gon\u00e7alves TH, Carvalho KC, Sim\u00f5es MJ, Garcia N, Soares JM, Padmanabhan V, Baracat EC, da Silva IDCG, et al. Impaired branched-chain amino acid metabolism May underlie the nonalcoholic fatty liver disease-like pathology of neonatal testosterone-treated female rats. Sci Rep. 2017;7(1):13167.","journal-title":"Sci Rep"},{"key":"6501_CR38","doi-asserted-by":"publisher","first-page":"113675","DOI":"10.1016\/j.psychres.2020.113675","volume":"297","author":"X Yu","year":"2021","unstructured":"Yu X, Qian-Qian L, Cong Y, Xiao-Bing Z, Hong-Zhu D. Reduction of essential amino acid levels and sex-specific alterations in serum amino acid concentration profiles in children with autism spectrum disorder. Psychiatry Res. 2021;297:113675.","journal-title":"Psychiatry Res"},{"issue":"1","key":"6501_CR39","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1097\/WCO.0000000000000405","volume":"30","author":"LI van Dyck","year":"2017","unstructured":"van Dyck LI, Morrow EM. Genetic control of postnatal human brain growth. Curr Opin Neurol. 2017;30(1):114\u201324.","journal-title":"Curr Opin Neurol"},{"issue":"1","key":"6501_CR40","doi-asserted-by":"publisher","first-page":"6084","DOI":"10.1038\/s41467-021-26131-z","volume":"12","author":"M Pagani","year":"2021","unstructured":"Pagani M, Barsotti N, Bertero A, Trakoshis S, Ulysse L, Locarno A, Miseviciute I, De Felice A, Canella C, Supekar K, et al. mTOR-related synaptic pathology causes autism spectrum disorder-associated functional hyperconnectivity. Nat Commun. 2021;12(1):6084.","journal-title":"Nat Commun"},{"issue":"20","key":"6501_CR41","doi-asserted-by":"publisher","first-page":"3447","DOI":"10.4161\/cc.10.20.17886","volume":"10","author":"AK Saha","year":"2011","unstructured":"Saha AK, Xu XJ, Balon TW, Brandon A, Kraegen EW, Ruderman NB. Insulin resistance due to nutrient excess: is it a consequence of AMPK downregulation? Cell Cycle. 2011;10(20):3447\u201351.","journal-title":"Cell Cycle"},{"key":"6501_CR42","doi-asserted-by":"crossref","unstructured":"Mao Z, Zhang W. Role of mTOR in glucose and lipid metabolism. Int J Mol Sci. 2018;19(7).","DOI":"10.3390\/ijms19072043"},{"issue":"12","key":"6501_CR43","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/nrendo.2014.171","volume":"10","author":"CJ Lynch","year":"2014","unstructured":"Lynch CJ, Adams SH. Branched-chain amino acids in metabolic signalling and insulin resistance. Nat Rev Endocrinol. 2014;10(12):723\u201336.","journal-title":"Nat Rev Endocrinol"},{"issue":"10","key":"6501_CR44","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.tins.2019.08.006","volume":"42","author":"A Rivell","year":"2019","unstructured":"Rivell A, Mattson MP. Intergenerational metabolic syndrome and neuronal network hyperexcitability in autism. Trends Neurosci. 2019;42(10):709\u201326.","journal-title":"Trends Neurosci"},{"issue":"1","key":"6501_CR45","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.nic.2019.09.009","volume":"30","author":"JB Girault","year":"2020","unstructured":"Girault JB, Piven J. The neurodevelopment of autism from infancy through toddlerhood. Neuroimaging Clin N Am. 2020;30(1):97\u2013114.","journal-title":"Neuroimaging Clin N Am"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-025-06501-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-025-06501-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-025-06501-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T09:57:42Z","timestamp":1772186262000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12887-025-06501-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,14]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6501"],"URL":"https:\/\/doi.org\/10.1186\/s12887-025-06501-y","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,14]]},"assertion":[{"value":"17 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This project was reviewed by the Ethics Committee of the First Affiliated Hospital of Henan University of Chinese Medicine and complies with the relevant provisions of the Measures for the Ethical Review of Biomedical Research Involving Humans and the Declaration of Helsinki regarding human biological experiments. The study protocol has been approved (Approval No.: 2025HL-549), and informed consent was obtained from all primary guardians.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"156"}}